For: | Manito N, Delgado JF, Crespo-Leiro MG, Arizón JM, Segovia J, González-Vílchez F, Mirabet S, Lage E, Pascual-Figal D, Díaz B, Palomo J, Rábago G, Sanz M, Blasco T, Roig E. Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients. World J Transplant 2015; 5(4): 310-319 [PMID: 26722659 DOI: 10.5500/wjt.v5.i4.310] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v5/i4/310.htm |
Number | Citing Articles |
1 |
Maaike A. Sikma, Claudine C. Hunault, Johannes H. Kirkels, Marianne C. Verhaar, Jozef Kesecioglu, Dylan W. de Lange. Association of Whole Blood Tacrolimus Concentrations with Kidney Injury in Heart Transplantation Patients. European Journal of Drug Metabolism and Pharmacokinetics 2018; 43(3): 311 doi: 10.1007/s13318-017-0453-7
|
2 |
Christophe Legendre, Richard Viebahn, Ingela Fehrman-Ekholm, Núria Masnou, Marina Berenguer, Luciano Potena, Lars Wennberg, John O’Grady, Eric Epailly, Fritz Diekmann, Isabelle Binet, Vedat Schwenger, Dirk Kuypers, Martina Guthoff. Long-term Challenges After Solid Organ Transplantation. Transplantation 2018; 102(9S1): S1 doi: 10.1097/TP.0000000000002316
|
3 |
N. N. Koloskova, E. A. Nikitina, V. M. Zakharevich, I. I. Muminov, V. S. Cvan, V. N. Poptsov, R. L. Ahmadzai, D. A. Izotov, A. O. Shevchenko. Conversion to everolimus to preserve kidney function in a heart transplant recipient, a personalized approach of immunos uppressive therapy. Russian Journal of Transplantology and Artificial Organs 2018; 20(3): 70 doi: 10.15825/1995-1191-2018-3-70-74
|
4 |
Niloufar Saber-Moghaddam, Homa Nomani, Amirhossein Sahebkar, Thomas P. Johnston, Amir Hooshang Mohammadpour. The change of immunosuppressive regimen from calcineurin inhibitors to mammalian target of rapamycin (mTOR) inhibitors and its effect on malignancy following heart transplantation. International Immunopharmacology 2019; 69: 150 doi: 10.1016/j.intimp.2019.01.035
|
5 |
Cristina Sánchez-Enrique, Ulrich P. Jorde, José González-Costello. Trasplante cardiaco y soporte circulatorio mecánico para pacientes con insuficiencia cardiaca avanzada. Revista Española de Cardiología 2017; 70(5): 371 doi: 10.1016/j.recesp.2016.10.032
|
6 |
David A. Baran. Rejection: the emperor’s new clothes. Transplant International 2020; 33(5): 500 doi: 10.1111/tri.13587
|
7 |
Cristina Sánchez-Enrique, Ulrich P. Jorde, José González-Costello. Heart Transplant and Mechanical Circulatory Support in Patients With Advanced Heart Failure. Revista Española de Cardiología (English Edition) 2017; 70(5): 371 doi: 10.1016/j.rec.2016.12.036
|
8 |
Kathrin Grimm, Anja Lehner, Silvia Fernandez Rodriguez, Madeleine Orban, Marcus Fischer, Laura L. Rosenthal, Andre Jakob, Nikolaus A. Haas, Robert Dalla Pozza, Rainer Kozlik‐Feldmann, Sarah M. Ulrich. Conversion to everolimus in pediatric heart transplant recipients is a safe treatment option with an impact on cardiac allograft vasculopathy and renal function. Clinical Transplantation 2021; 35(3) doi: 10.1111/ctr.14191
|